Yasui‐Furukori, N., Muraoka, H., Hasegawa, N., Ochi, S., Numata, S., Hori, H., . . . Miura, K. (2022). Association between the examination rate of treatment‐resistant schizophrenia and the clozapine prescription rate in a nationwide dissemination and implementation study. Neuropsychopharmacology Reports, 42(1), 3. https://doi.org/10.1002/npr2.12218
Chicago Style (17th ed.) CitationYasui‐Furukori, Norio, et al. "Association Between the Examination Rate of Treatment‐resistant Schizophrenia and the Clozapine Prescription Rate in a Nationwide Dissemination and Implementation Study." Neuropsychopharmacology Reports 42, no. 1 (2022): 3. https://doi.org/10.1002/npr2.12218.
MLA (9th ed.) CitationYasui‐Furukori, Norio, et al. "Association Between the Examination Rate of Treatment‐resistant Schizophrenia and the Clozapine Prescription Rate in a Nationwide Dissemination and Implementation Study." Neuropsychopharmacology Reports, vol. 42, no. 1, 2022, p. 3, https://doi.org/10.1002/npr2.12218.